SCHEMBL1404045

SCHEMBL1404045

[O]C1(O)CC2CCN1CC2

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3390481 0.70
SCHEMBL16054051 0.69 EPHX1 (0.33) HSD11B1L3MBTL1
SCHEMBL21436460 0.67 MEN1 (0.35)
SCHEMBL3756087 0.67
SCHEMBL21391723 0.63
SCHEMBL4961193 0.63 LMNA (0.35)
SCHEMBL6530929 0.61
SCHEMBL28204440 0.60 LMNA (0.32)
SCHEMBL21095682 0.55
SCHEMBL8646647 0.52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2291374-A1 PROCESS FOR PREPARATION OF SOLIFENACIN AND/OR THE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF OF HIGH PHARMACEUTICAL PURITY Zaklady Farmaceutyczne "Polpharma" S.A. (PL) 2011-03-09 EP claimed
WO-2009142522-A1 PROCESS FOR PREPARATION OF SOLIFENACIN AND/OR THE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF OF HIGH PHARMACEUTICAL PURITY ZAKLADY FARMACEUTYCZNE POLPHARMA SA (PL) 2009-11-26 WO claimed